Haemonetics | HAE - Gross Profit On Sales

Stock Price
60.85
Daily Change
-4.17 -6.41%
Monthly
-26.69%
Yearly
2.54%
Q1 Forecast
64.61

Haemonetics reported $202.39M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Avanos Medical USD 86M 6.1M Sep/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Fresenius EUR 1.3B 158M Sep/2025
Fresenius Medical Care EUR 1.24B 27M Sep/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
ICU Medical USD 200.88M 7.18M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Medtronic USD 5.44B 123M Sep/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Neogen USD 94.97M 2.11M Jun/2025
Quidel USD -733M 1.01B Sep/2025
ResMed USD 878.72M 57.9M Dec/2025
STAAR Surgical USD 77.88M 45.08M Sep/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Teleflex USD 451.64M 20.56M Sep/2025
Terumo JPY 147B 1.53B Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
US Physical Therapy USD 36.87M 4.75M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025